128 related articles for article (PubMed ID: 12467626)
1. Structure-activity and crystallographic analysis of benzophenone derivatives-the potential anticancer agents.
Hsieh HP; Liou JP; Lin YT; Mahindroo N; Chang JY; Yang YN; Chern SS; Tan UK; Chang CW; Chen TW; Lin CH; Chang YY; Wang CC
Bioorg Med Chem Lett; 2003 Jan; 13(1):101-5. PubMed ID: 12467626
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents.
Liou JP; Chang CW; Song JS; Yang YN; Yeh CF; Tseng HY; Lo YK; Chang YL; Chang CM; Hsieh HP
J Med Chem; 2002 Jun; 45(12):2556-62. PubMed ID: 12036364
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents.
Liou JP; Chang JY; Chang CW; Chang CY; Mahindroo N; Kuo FM; Hsieh HP
J Med Chem; 2004 May; 47(11):2897-905. PubMed ID: 15139768
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, antitumor activity, and structure-activity relationship of some benzo[a]pyrano[2,3-c]phenazine derivatives.
Gao J; Chen M; Tong X; Zhu H; Yan H; Liu D; Li W; Qi S; Xiao D; Wang Y; Lu Y; Jiang F
Comb Chem High Throughput Screen; 2015; 18(10):960-74. PubMed ID: 26369405
[TBL] [Abstract][Full Text] [Related]
5. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
[TBL] [Abstract][Full Text] [Related]
6. Antineoplastic agents. 443. Synthesis of the cancer cell growth inhibitor hydroxyphenstatin and its sodium diphosphate prodrug.
Pettit GR; Grealish MP; Herald DL; Boyd MR; Hamel E; Pettit RK
J Med Chem; 2000 Jul; 43(14):2731-7. PubMed ID: 10893310
[TBL] [Abstract][Full Text] [Related]
7. Benzophenone-nucleoside derivatives as telomerase inhibitors: Design, synthesis and anticancer evaluation in vitro and in vivo.
Shi JB; Chen LZ; Wang Y; Xiou C; Tang WJ; Zhou HP; Liu XH; Yao QZ
Eur J Med Chem; 2016 Nov; 124():729-739. PubMed ID: 27639364
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiproliferative activity of conformationally restricted 1,2,3-triazole analogues of combretastatins in the sea urchin embryo model and against human cancer cell lines.
Demchuk DV; Samet AV; Chernysheva NB; Ushkarov VI; Stashina GA; Konyushkin LD; Raihstat MM; Firgang SI; Philchenkov AA; Zavelevich MP; Kuiava LM; Chekhun VF; Blokhin DY; Kiselyov AS; Semenova MN; Semenov VV
Bioorg Med Chem; 2014 Jan; 22(2):738-55. PubMed ID: 24387982
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of novel benzophenone derivatives.
Kumazawa E; Hirotani K; Burford SC; Kawagoe K; Miwa T; Mitsui I; Ejima A
Chem Pharm Bull (Tokyo); 1997 Sep; 45(9):1470-4. PubMed ID: 9331999
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents.
Pirali T; Busacca S; Beltrami L; Imovilli D; Pagliai F; Miglio G; Massarotti A; Verotta L; Tron GC; Sorba G; Genazzani AA
J Med Chem; 2006 Aug; 49(17):5372-6. PubMed ID: 16913727
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a resveratrol structural modification.
Pettit GR; Melody N; Thornhill A; Knight JC; Groy TL; Herald CL
J Nat Prod; 2009 Sep; 72(9):1637-42. PubMed ID: 19719153
[TBL] [Abstract][Full Text] [Related]
12. Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agents.
Siles R; Ackley JF; Hadimani MB; Hall JJ; Mugabe BE; Guddneppanavar R; Monk KA; Chapuis JC; Pettit GR; Chaplin DJ; Edvardsen K; Trawick ML; Garner CM; Pinney KG
J Nat Prod; 2008 Mar; 71(3):313-20. PubMed ID: 18303849
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activity of fluorinated combretastatin analogues.
Alloatti D; Giannini G; Cabri W; Lustrati I; Marzi M; Ciacci A; Gallo G; Tinti MO; Marcellini M; Riccioni T; Guglielmi MB; Carminati P; Pisano C
J Med Chem; 2008 May; 51(9):2708-21. PubMed ID: 18396857
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel 3,4-diaryl-1,2,5-selenadiazol analogues of combretastatin A-4.
Guan Q; Yang F; Guo D; Xu J; Jiang M; Liu C; Bao K; Wu Y; Zhang W
Eur J Med Chem; 2014 Nov; 87():1-9. PubMed ID: 25233100
[TBL] [Abstract][Full Text] [Related]
15. Antimitotic activity of diaryl compounds with structural features resembling combretastatin A-4.
Aleksandrzak K; McGown AT; Hadfield JA
Anticancer Drugs; 1998 Jul; 9(6):545-50. PubMed ID: 9877243
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
[TBL] [Abstract][Full Text] [Related]
17. Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure⁻Activity Relations of New Inhibitors of HDAC and/or Tubulin Function.
Schmitt F; Gosch LC; Dittmer A; Rothemund M; Mueller T; Schobert R; Biersack B; Volkamer A; Höpfner M
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658435
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and anticancer properties of novel benzophenone-conjugated coumarin analogs.
Lakshmi Ranganatha V; Zameer F; Meghashri S; Rekha ND; Girish V; Gurupadaswamy HD; Khanum SA
Arch Pharm (Weinheim); 2013 Dec; 346(12):901-11. PubMed ID: 24170414
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of diamide-coupled benzophenones as potential anticancer agents.
Zabiulla ; Shamanth Neralagundi HG; Bushra Begum A; Prabhakar BT; Khanum SA
Eur J Med Chem; 2016 Jun; 115():342-51. PubMed ID: 27027818
[TBL] [Abstract][Full Text] [Related]
20. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
